Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Evelyn DeSantis
Evelyn R. Hermes-DeSantis, PharmD, BCPS, is the Director for Research and Publications for phactMI and Professor Emerita at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. She is dedicated to advancing and elevating the practice of medical information.
phactMI is a non-profit association representing medical information leadership of 30+ pharma companies. phactMI is an industry-wide consortium that focuses on increasing the awareness, credibility, and access to medical information. At phactMI, Evelyn has overseen and conducted numerous projects that have resulted in presentations and publications; precepted and mentored fellows; and has provided continuing education programs focused in medical information.
Prior to joining phactMI, Evelyn was a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey and Director of Drug Information Services at Robert Wood Johnson University Hospital. In her role she was dedicated to training student pharmacists, residents, and fellows in medical information skills including medical literature evaluation and application. Her research focused in the area of provision of drug information services within in institutions, the relationship between hospital and industrial pharmacy practice, and education of pharmacists. She also has expertise in research study procedure design. She worked with the Rutgers Industry Pharmacy Fellowship program and mentored numerous fellows on their research project over the years.
Evelyn received both a bachelor’s degree (BS) in Pharmacy and a doctorate in pharmacy (PharmD) from Rutgers, The State University of New Jersey. She then completed a Drug Information specialty residency at the Medical College of Virginia Hospital in Richmond, Virginia prior to working at the University of Utah Hospital Drug Information Service for a few years.–
Fatima Ahmad
Fatima Ahmad, PharmD is Vice President of Medical Affairs at Castle Creek Biosciences, a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options. Previously, she held positions at Spark Therapeutics, a member of the Roche group, including heading the Medical Communications team responsible for leading integrated Medical Communications Strategies across therapeutic areas in Spark’s portfolio of AAV-based investigational gene therapies, as well as serving as Therapeutic Area Leader for hematology. Previously, Fatima spent time at Advaxis Immunotherapies as Senior Director Medical Affairs and at Otsuka Pharmaceuticals, where she held roles of increasing seniority in US and Global Medical Affairs.
Fatima began her industry career at AstraZeneca where she was a Pharmacy intern and subsequently held roles in Medical Information and Medical Communication Science, working across several therapeutic areas including respiratory and oncology. She graduated Magna Cum Laude from Temple University with a PharmD degree, and practiced community pharmacy briefly before transitioning to the pharmaceutical industry. Fatima is passionate about incorporating a patient-centric approach to all aspects of Medical Affairs and is committed to the evolution of Medical Affairs in best serving patients in the era of personalized medicine and novel therapeutic modalities.
